The medicine "Berodual" refers to a combination type bronchodilator. The drug is used in the treatment and for the prevention of suffocation against the background of chronic diseases of the respiratory tract of an obstructive nature. The medication has a bronchodilating property with bronchospasm.
Active ingredients: ipratropium bromide and fenoterol. The combination of components significantly increases the effectiveness of bronchodilator treatment of diseases accompanied by hypersecretion of mucus and increased tone in the bronchial muscles. The specified combination of substances also has a longer lasting effect than each ingredient individually. When using the drug "Berodual", the instruction indicates a decrease in the dose of the beta-adrenergic component. Thus, it becomes possible to avoid side effects and achieve the greatest safety of use.
For patients with chronic bronchopulmonary pathologies, Berodual is especially convenient for attacks of bronchospasm. With COPD (chronic obstructive pulmonary disease), there is a significant improvement in respiratory function over the course of fifteen minutes. The maximum effectiveness of the drug is noted after an hour or two, continuing in a large number of patients up to six hours after the use of the medication.
The drug "Berodual" begins to act immediately after inhalation. This allows you to use the medicine to stop an asthma attack.
The drug "Berodual." Instruction Indications.
The drug is prescribed for symptomatic treatment and prevention of obstructive respiratory tract pathologies in a chronic course with reversible bronchospasm. Such diseases include bronchial asthma of non-allergic and allergic nature, physical stress (for the prevention and treatment of acute asthma attacks ), COPD, respiratory failure due to bronchopulmonary diseases accompanied by bronchial obstruction syndrome.
Berodual instruction is recommended for use in the preparation (for "expansion of the bronchi") and to facilitate aerosol treatment using antibiotic, secretion-mucolytic agents, cromoglycate sodium, corticosteroids.
It is advisable to use the drug in the implementation of bronchodilator samples of HPF (external respiration function ).
The drug "Berodual." Instructions for use.
When using a dosed aerosol, as a rule, two doses are enough to stop the symptoms of an attack of bronchospasm. In the absence of a pronounced effect in more severe cases, after five minutes it is allowed to inhale one or two doses of the drug. The following inhalation with the Berodual medication is recommended by the instruction not earlier than two hours from the last use. If there is no result after four consecutive inhalations, additional inhalations are required, and you should immediately seek help. The maximum dose is eight inhalations per day.
The regimen for the use of the drug is selected by the attending physician in accordance with the indications.
To achieve the effect, certain recommendations must be followed when using the Berodual product.
Shake the inhaler before use for the first time and press the valve twice.
For subsequent use, it is recommended that certain rules be followed each time.
- Remove the cap.
- Exhale deeply and slowly.
- Grasp the tip with your lips. The bottom of the container should be pointing up.
- With the deepest breath possible, quickly press the bottom until a single dose of the drug is released.
- Hold your breath for a few seconds, remove the tip from your mouth. Exhale slowly.
- To obtain a second inhalation dosage, the steps are repeated.
- Put on the cap.
If the inhaler has not been used for more than three days, before performing inhalation, you should press the valve once, until an aerosol cloud appears.